Literature DB >> 28138635

Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer.

Zhong-He Ji1, Kai-Wen Peng1, Yan Li1.   

Abstract

Peritoneal carcinomatosis (PC) is one of the most common causes of death in gastric cancer patients. Intraperitoneal free cancer cells (IFCCs) play a very important role in forming PC, but the administration of intraperitoneal chemotherapy (IPC) and/or hyperthermic intraperitoneal chemotherapy (HIPEC) could be an effective treatment for IFCCs. This review focuses on the origin of IFCCs, the mechanism of PC formatting, the rationale of IPC/HIPEC, and the current clinical trials on IPC/HIPEC to treat advanced gastric cancer patients.

Entities:  

Keywords:  Intraperitoneal free cancer cells (IFCCs); gastric cancer (GC); hyperthermic intraperitoneal chemotherapy (HIPEC); intraperitoneal chemotherapy (IPC); peritoneal carcinomatosis (PC)

Year:  2016        PMID： 28138635      PMCID： PMC5244747          DOI： 10.21037/tgh.2016.08.03

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


  77 in total

1.  Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis.

Authors:  K Hirose; K Katayama; A Iida; A Yamaguchi; G Nakagawara; S Umeda; Y Kusaka
Journal:  Oncology       Date:  1999       Impact factor: 2.935

2.  Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.

Authors:  S Fujimoto; M Takahashi; T Mutou; K Kobayashi; T Toyosawa; E Isawa; M Sumida; H Ohkubo
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

3.  Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial.

Authors:  Yasuhiro Kodera; Naoto Takahashi; Takaki Yoshikawa; Nobuhiro Takiguchi; Kazumasa Fujitani; Yuichi Ito; Katsufumi Miyamoto; Osamu Takayama; Motohiro Imano; Daisuke Kobayashi; Yumi Miyashita; Satoshi Morita; Junichi Sakamoto
Journal:  Gastric Cancer       Date:  2016-02-15       Impact factor: 7.370

4.  A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).

Authors:  J Y Kim; H S Bae
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

5.  Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis.

Authors:  Motohiro Imano; Atsushi Yasuda; Tatsuki Itoh; Takao Satou; Ying-Feng Peng; Hiroaki Kato; Masayuki Shinkai; Masahiro Tsubaki; Yasutaka Chiba; Takushi Yasuda; Haruhiko Imamoto; Shozo Nishida; Yoshifumi Takeyama; Kiyokata Okuno; Hiroshi Furukawa; Hitoshi Shiozaki
Journal:  J Gastrointest Surg       Date:  2012-10-26       Impact factor: 3.452

6.  Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

Authors:  H Ishigami; J Kitayama; S Kaisaki; A Hidemura; M Kato; K Otani; T Kamei; D Soma; H Miyato; H Yamashita; H Nagawa
Journal:  Ann Oncol       Date:  2009-07-15       Impact factor: 32.976

7.  Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study.

Authors:  T Fujimura; Y Yonemura; K Muraoka; H Takamura; Y Hirono; H Sahara; I Ninomiya; H Matsumoto; K Tsugawa; G Nishimura
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

8.  Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.

Authors:  O Glehen; V Schreiber; E Cotte; A C Sayag-Beaujard; D Osinsky; G Freyer; Y François; J Vignal; F N Gilly
Journal:  Arch Surg       Date:  2004-01

9.  Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.

Authors:  S Fushida; J Kinoshita; M Kaji; Y Hirono; F Goda; Y Yagi; K Oyama; Y Sudo; Y Watanabe; T Fujimura
Journal:  Cancer Chemother Pharmacol       Date:  2013-02-20       Impact factor: 3.333

10.  Assessment of Hyperthermic Intraperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells.

Authors:  Zhonghe Ji; Jianhua Sun; Haitao Wu; Qian Zhang; Kaiwen Peng; Yan Li
Journal:  Transl Oncol       Date:  2016-01-23       Impact factor: 4.243
View more
  6 in total

Review 1.  Intra-operative hyperthermic intraperitoneal chemotherapy for prevention and treatment of peritoneal metastases from gastric cancer: a narrative review.

Authors:  Zhong-He Ji; Ying Zhang; Yan Li
Journal:  J Gastrointest Oncol       Date:  2021-04

2.  Hyperthermia potentiates cisplatin cytotoxicity and negative effects on mitochondrial functions in OVCAR-3 cells.

Authors:  Arturas Sukovas; Giedre Silkuniene; Sonata Trumbeckaite; Aldona Jasukaitiene; Laima Degutyte-Fomins; Vida Mildaziene; Antanas Gulbinas; Rasa Baniene; Zilvinas Dambrauskas; Saulius Paskauskas
Journal:  J Bioenerg Biomembr       Date:  2019-07-22       Impact factor: 2.945

3.  Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?

Authors:  Hae Young Kim; Young Hoon Kim; Gabin Yun; Won Chang; Yoon Jin Lee; Bohyoung Kim
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

Review 4.  Ferroptosis-Inducing Nanomedicine for Cancer Therapy.

Authors:  Yang Wang; Tianfu Liu; Xiang Li; Hui Sheng; Xiaowen Ma; Liang Hao
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

Review 5.  Free cancer cells in gastric cancer - methods of detection, clinical and prognostic importance (meta-analysis).

Authors:  Magdalena M Kołomańska; Stanisław Głuszek
Journal:  Contemp Oncol (Pozn)       Date:  2020-03-30

Review 6.  A case report of appendix mucinous adenocarcinoma that recurred after additional surgery and a brief literature review.

Authors:  Wei Chen; Jun-Wen Ye; Xiao-Ping Tan; Xiang Peng; Yan Zhang; Jing-Lin Liang; Mei-Jin Huang
Journal:  BMC Surg       Date:  2020-08-10       Impact factor: 2.102
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.